Literature DB >> 29863096

Prognostic Value of Electrocardiography in Patients With Fulminant Myocarditis Supported by Percutaneous Venoarterial Extracorporeal Membrane Oxygenation - Analysis From the CHANGE PUMP Study.

Akinori Sawamura1, Takahiro Okumura1, Masaaki Ito2, Yukio Ozaki3, Nobuyuki Ohte4, Tetsuya Amano5, Toyoaki Murohara1.   

Abstract

BACKGROUND: Fulminant myocarditis (FM) presents various abnormal findings on ECG, the prognostic impact of which has not been not fully elucidated. The aim of this study was therefore to clarify the prognostic value of ECG data in FM patients supported by venoarterial extracorporeal membrane oxygenation (VA-ECMO).Methods and 
Results: In this multicenter chart review, we investigated 99 patients with FM supported by VA-ECMO. The final cohort consisted of 87 patients (mean age, 52±16 years; female, 42%) after 12 patients who required conversion to other forms of mechanical circulatory support were excluded. The median LVEF was 14.5%. At the time of VA-ECMO initiation, 38 patients (44%) had arrhythmias including atrial fibrillation (6%), complete atrioventricular block (CAVB; 17%), and ventricular tachycardia or fibrillation (VT/VF; 15%). Of the 49 patients with sinus rhythm (SR), 26 had QRS duration ≥120 ms (wide QRS). On logistic regression analysis, wide QRS predicted in-hospital death in patients with SR (OR, 3.6; 95% CI: 1.07-13.61, P=0.04). Compared with SR with narrow QRS (QRS duration <120 ms), CAVB and VT/VF had a higher risk of in-hospital death (CAVB: OR, 7.20; 95% CI: 1.78-34.15, P=0.005; VT/VF: OR, 8.10; 95% CI: 1.86-42.31, P=0.005).
CONCLUSIONS: In patients with FM, CAVB and VT/VF carried a higher risk of in-hospital death. Wide QRS also predicted a higher risk of in-hospital death in patients with SR.

Entities:  

Keywords:  Electrocardiogram; Extracorporeal circulation; Myocarditis; Prognosis

Mesh:

Year:  2018        PMID: 29863096     DOI: 10.1253/circj.CJ-18-0136

Source DB:  PubMed          Journal:  Circ J        ISSN: 1346-9843            Impact factor:   2.993


  11 in total

Review 1.  Acute and Fulminant Myocarditis: a Pragmatic Clinical Approach to Diagnosis and Treatment.

Authors:  Enrico Ammirati; Giacomo Veronese; Manlio Cipriani; Francesco Moroni; Andrea Garascia; Michela Brambatti; Eric D Adler; Maria Frigerio
Journal:  Curr Cardiol Rep       Date:  2018-09-26       Impact factor: 2.931

2.  First case of COVID-19 complicated with fulminant myocarditis: a case report and insights.

Authors:  Jia-Hui Zeng; Ying-Xia Liu; Jing Yuan; Fu-Xiang Wang; Wei-Bo Wu; Jin-Xiu Li; Li-Fei Wang; Hong Gao; Yao Wang; Chang-Feng Dong; Yi-Jun Li; Xiao-Juan Xie; Cheng Feng; Lei Liu
Journal:  Infection       Date:  2020-04-10       Impact factor: 3.553

3.  Risk factors analysis of prognosis of adult acute severe myocarditis.

Authors:  Qian Zhang; Rui Zhao
Journal:  World J Clin Cases       Date:  2020-11-26       Impact factor: 1.337

4.  The diagnostic capability of electrocardiography on the cardiogenic shock in the patients with acute myocarditis.

Authors:  Dan Yang; Qing Dai; Han Wu; Jianzhou Chen; Jingmei Zhang; Zhonghai Wei
Journal:  BMC Cardiovasc Disord       Date:  2020-12-01       Impact factor: 2.298

Review 5.  Diagnostic and prognostic role of electrocardiogram in acute myocarditis: A comprehensive review.

Authors:  Carmelo Buttà; Luca Zappia; Giulia Laterra; Marco Roberto
Journal:  Ann Noninvasive Electrocardiol       Date:  2019-11-28       Impact factor: 1.468

6.  Myocardial strain features by 2D-STE during the course of fulminant myocarditis: Correlation with characteristics by CMR and clinical implications.

Authors:  Houjuan Zuo; Haojie Li; Rui Li; Fei Ma; Jiangang Jiang; Chenze Li; Liming Xia; Hong Wang; Dao Wen Wang
Journal:  Medicine (Baltimore)       Date:  2021-04-16       Impact factor: 1.817

Review 7.  Fulminant myocarditis: a comprehensive review from etiology to treatments and outcomes.

Authors:  Weijian Hang; Chen Chen; John M Seubert; Dao Wen Wang
Journal:  Signal Transduct Target Ther       Date:  2020-12-11

8.  Differences in Prognosis and Cardiac Function According to Required Percutaneous Mechanical Circulatory Support and Histological Findings in Patients With Fulminant Myocarditis: Insights From the CHANGE PUMP 2 Study.

Authors:  Toru Kondo; Takahiro Okumura; Naoki Shibata; Takahiro Imaizumi; Kaoru Dohi; Hideo Izawa; Nobuyuki Ohte; Tetsuya Amano; Toyoaki Murohara
Journal:  J Am Heart Assoc       Date:  2022-02-08       Impact factor: 6.106

9.  Sinus Node Dysfunction Co-occurring with Immune Checkpoint Inhibitor-associated Myocarditis.

Authors:  Tatsuya Nishikawa; Kei Kunimasa; Keiko Ohta-Ogo; Yoshihiko Ikeda; Taku Yasui; Wataru Shioyama; Toru Oka; Keiichiro Honma; Kinta Hatakeyama; Toru Kumagai; Masashi Fujita
Journal:  Intern Med       Date:  2022-03-12       Impact factor: 1.282

10.  Case report of an isolated myocarditis due to COVID-19 infection in a paediatric patient.

Authors:  Quentin Fischer; Nina Brillat-Savarin; Grégory Ducrocq; Phalla Ou
Journal:  Eur Heart J Case Rep       Date:  2020-07-03
View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.